The CaPP3 Study Day for UK site teams was held in London on 29th September 2017

posted on Thursday, 12th October 2017

Not tagged.


The CaPP3 study was delighted to be able to hold a study day, on 29th September, to meet with the CaPP3 study teams from around the UK.

The meeting was held at Friends House in London; CaPP3 teams from 22 of the 26 UK sites attended. The Chief Investigator John Burn welcomed the CaPP3 personnel and gave a talk entitled 'Why repurpose aspirin?', showing the increasing weight of evidence for aspirin to be prescribed for cancer prevention, especially in high risk populations. Richard Gallon, PhD student with the CaPP3 study at Newcastle University, talked to the group about his Lynch Syndrome related research. It was also an opportunity to discuss the recent amendment to the open phase of the study and address any problems with study systems. 

Share this!

Latest News


  • Review of the role of aspirin in preventing colorectal cancer

    posted on Tuesday, 24th October 2017

    Review of the role of aspirin in preventing colorectal cancer written by John Burn and his postdoctoral research assistant Harsh Sheth

  • Lynch Syndrome UK

    posted on Thursday, 5th March 2015

    Lynch Syndrome UK is a registered charity stemming from a long running support group on Facebook.  Our many members are passionate about our cause to educate and empower people living with this genetic condition and offering support to both them and their families when they need it most.